key: cord-0783123-uvef4pxi
authors: Di Bella, Stefano; Cabas, Paolo; Antonello, Roberta Maria; Rizzo, Michele
title: Interferon: The invisible link in the physiopathology of COVID‐19 and BCGitis?
date: 2020-08-04
journal: Scand J Immunol
DOI: 10.1111/sji.12939
sha: 088066719390e1322332b925346f7e656ab2f27c
doc_id: 783123
cord_uid: uvef4pxi

Gender distribution of COVID-19 severity is unbalanced. Higher mortality rates are reported in men (60-70% deaths in men). We reviewed 243 BCGitis cases reported in the literature. The M/F ratio in BCGitis is 49:1 and is not fully explained by the higher incidence of bladder cancer among males, neither by anatomical reasons. We discuss the M/F ratio in BCGitis in the light of immune system differences among different genders, with a focus on interferon response (higher in females).

Dear editor, Facing the COVID-19 pandemic, we were intrigued by the difference of incidence and disease severity between men and women (60%-70% of deaths occurring in men). This disparity remains significant even after age stratification in all age groups (postmenopausal women vs age-matched men), suggesting a partially hormone-independent mechanism.

Coincidentally, during the last month we were reviewing the infectious complications of Bacillus Calmette-Guerin (BCG) bladder instillation. BCG is used for non-muscle-invasive bladder cancer (NMIBC) after standard surgical treatment: surprisingly, among 243 BCGitis cases reported in the literature, only three were female.

The higher number of BCGitis in men has been justified so far considering the worldwide M/F ratio for bladder cancer (3.5:1). 1 In addition, for anatomical reasons, traumatic catheterization is more common in men, potentially providing a wider port of entry for systemic BCG dissemination. 2 However, these two issues are not strong enough to justify the overwhelming unbalanced gender ratio found in BCGitis (M/F 49:1).

Bacillus Calmette-Guerin acts against NMIBC mainly by stimulating non-specific immune response and a torrent of Th-1 cytokines, including IFN-γ. 3 IFN-γ plays a role against intracellular infection by pathogens such as Mycobacterium tuberculosis and Mycobacterium bovis. 4 A reduced level of IFN-γ has been observed in men, both prior than after surgery. 5 Bacillus Calmette-Guerin used as a tubercular vaccine is generally administered to young patients and induced IgG and IFNγ generally diminish with age if a booster dose is not given. 4 On the contrary, BCG used as immune therapy for non-muscle-invasive bladder cancer is administered to adult elderly patients, and according to the schedule of the treatment, the instillations are repeated periodically resulting in a more sustained immune response.

Constitutional differences in male and female immune systems have long been described. The underlying biological mechanisms are not fully understood. They are supposed to result from steroid hormones secreted by gonads and/or different cytokines response.

With regard to steroid hormones, in vivo studies 6-8 reported a protective role of oestrogens against respiratory infections. For instance, high levels of 17β-estradiol are related to better clinical outcomes in mice infected with influenza A. 6 Inflammatory immune responses, as well as the number and activity of innate immune cells, are higher in women. Human studies demonstrated that plasmacytoid dendritic cells of woman exhibit increased expression of interferon (IFN)-α, following toll-like receptor (TLR)-7 stimulation. 9 Furthermore, TLR-associated genes that activate IFN pathway are significantly upregulated in woman after vaccinations. 10 To be kept in mind, both in vitro and in vivo studies demonstrated the efficient role of IFNs against SARS-CoV. 11, 12 In light of the above, we hypothesize that major susceptibility of male gender to COVID-19 and to BCG infection might share a common interferon-centred physiopathological basis that needs to be deeply investigated (Figure 1 ).

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Managing the adverse events of intravesical bacillus Calmette-Guèrin therapy

The use of intravesical BCG in urothelial carcinoma of the bladder

Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report

Sex differences in cytokine production and surface antigen expression of peripheral blood mononuclear cells after surgery

Elevated 17β-estradiol protects females from influenza a virus pathogenesis by suppressing inflammatory responses

Modulation of 17be-ta-estradiol on the number and cytotoxicity of NK cells in vivo related to MCM and activating receptors

17β-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells

Human immunodeficiency virus 1 and type I interferons-where sex makes a difference

The Xs and Y of immune responses to viral vaccines

Treatment of SARS with human interferons

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study